Many recent studies have found a clear link between use of the drug Elmiron and a unique type of macular degeneration. As a result, hundreds of people have filed Elmiron lawsuits against Johnson & Johnson and their pharmaceutical subsidiary, Janssen, alleging that the company’s bladder drug Elmiron caused them to suffer from vision loss.
November 2018 Ophthalmology study
A November 2018 study published in Ophthalmology found an association between Elmiron exposure and pigmentary maculopathy. The researchers examined the medical records of six Elmiron patients who suffered from pigmentary maculopathy. The patients’ ages ranged between 37 and 62 years. They used Elmiron for an average of 15.5 years.